Financials
- Financial year
- 2025
- Total assets
- €18,455
- Profit
- €11,561
- Solvency
- 76.2%
Dr. Tom Verresen
ActiveSummary
Dr. Tom Verresen is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €14,061 and a net result of €11,561. The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
“Rekening houdend met de bepalingen van de geneeskundige plichtenleer, het volledig uitoefenen van de…” (deed in Dutch)
From the articles, 14 activitiesNo NACE code in the KBO yet1 site
Size
€18,455total assets 2025
- Equity
- €14,061
- Profit
- €11,561
Turnover not published (micro format)
Signalsraises riskYoung company2025 accounts filed 28 days lateShow the evidence
Checked score
Score 2025
97
/ 100
Excellent
Without a bankruptcy probability: score from the figures alone
Financial strength
Strong
Solvency
100
equity 76.2% of total assets
Liquidity
91
short-term debt 23.8% · cash 58.3%
Profitability
100
return on assets 62.6%
Bankruptcy probability, 12 months
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.2, above the usual 1.5; short-term debt: 23.8% and cash: 58.3% of total assets), and 23.8% of the assets are financed with debt and provisions.
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Two signals.
raises risk
raises risk · Young company
Founded in 2025, less than a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
28 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: VERRESEN Tom Louis Jacqueline…
Key points
By topic
Board & ownership
- Board
- 1 member
- VERRESEN Tom Louis JacquelineDirector
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Founded
- 09-12-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 70
- Annual meeting
- First Tuesday of June at 20:00
- Purpose
- “Rekening houdend met de bepalingen van de geneeskundige plichtenleer, het volledig…” (deed in Dutch)
- Statutory auditor
- No statutory auditor
Key facts about Dr. Tom Verresen
- What is the company number of Dr. Tom Verresen?
- 1031.342.503. In Belgium the VAT number is the company number with BE in front: BE 1031.342.503.
- Where is Dr. Tom Verresen based?
- The registered office is at Floraliënlaan 483, 2610 Antwerpen.Company details
- What is the legal form of Dr. Tom Verresen?
- Private limited company (BV).
- When was Dr. Tom Verresen founded?
- On 09-12-2025.
- Is Dr. Tom Verresen still active?
- Yes, Dr. Tom Verresen is an active enterprise in the KBO register.
- What is the turnover of Dr. Tom Verresen?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Dr. Tom Verresen profitable?
- In financial year 2025, Dr. Tom Verresen made a profit of €11,561.
- Where can I find the annual accounts of Dr. Tom Verresen?
- Dr. Tom Verresen filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.